The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

To discourage price hikes on brand-name drugs, the IRA requires manufacturers to pay inflation rebates to Medicare if prices ...

Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

While the Trump administration says it has more drug pricing deals lined up with pharmaceutical manufacturers, the emerging ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Sprouts employs approximately 35,000 associates and operates more than 450 stores in 24 states nationwide. The Phoenix-based ...

The reporting duo demonstrate how drugmakers exploit public funding and legal loopholes to turn high profits, while ...

One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Pharmaceutical companies are better positioned to understand what information physicians want—and how to generate it quickly ...